New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6′-homoneplanocin A

Journal of Medicinal Chemistry

Volumn 39, Issue 12, 1996, Pages 2392-2399

  Shuto, Satoshi ^a   Obara, Takumi ^b   Saito, Yasuyoshi ^b   Andrei, Graciela ^c   Snoeck, Robert ^c   De Clercq, Erik ^c   Matsuda, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b ASAHI CHEMICAL INDUSTRY CO   (Japan)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

6' HOMONEPLANOCIN A; ANTIVIRUS AGENT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARENAVIRUS; ARTICLE; CYTOMEGALOVIRUS; DRUG POTENCY; DRUG SYNTHESIS; RNA VIRUS INFECTION; STRUCTURE ACTIVITY RELATION; VACCINIA; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ADENOSINE; ADENOSYLHOMOCYSTEINASE; ANIMALS; ANTIVIRAL AGENTS; ARENAVIRUSES, NEW WORLD; CATTLE; CERCOPITHECUS AETHIOPS; CYCLOPENTANES; CYTOMEGALOVIRUS; DRUG DESIGN; ENZYME INHIBITORS; FIBROBLASTS; HELA CELLS; HERPESVIRIDAE; HUMANS; HYDROLASES; MOLECULAR STRUCTURE; PARAINFLUENZA VIRUS 3, HUMAN; PICORNAVIRIDAE; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP; TOGAVIRIDAE; VACCINIA VIRUS; VERO CELLS; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0029894001     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950853f     Document Type: Article

References (35)

1. This paper constitutes Part 148 of Nucleosides and Nucleotides. Part 147: Kakefuda, A.; Masuda, A.; Ueno, Y.; Ono, A.; Matsuda, A. Synthesis of DNA dodecamers containing oxetanocin A and (2R,3R)-2-C-(adenin-9-yl)-1,4-anhydro-1,3-dideoxy-3-C-hydroxymethyl-D-arabitol. Tetrahedron 1996, 52, 2863-2876.
2. Ueland, P. M. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol. Rev. 1982, 34, 223-253.
3. Wolfe, M. S.; Borchardt, R. T. S-Adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy. J. Med. Chem. 1991, 34, 1521-1530.
4. (a) De Clercq, E. S-Adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Biochem. Pharmacol. 1987, 36, 2567-2575.
5. (b) Snoeck, R.; Andrei, G.; Neyts, J.; Schols, D.; Cools, M.; Balzarini, J.; De Clercq, E. Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication. Antiviral Res. 1993, 21, 197-216.
6. (c) De Clercq, E. Antiviral activity spectrum and target of action of different classes of nucleoside analogues. Nucleosides Nucleotides 1994, 13, 1271-1295.
7. (d) De Clercq, E.; Bergstrom, D. E.; Holy, A.; Montgomery, J. A. Broad-spectrum antiviral activity of adenosine analogues. Antiviral Res. 1984, 4, 119-133.
8. (e) Matsuda, A.; Kosaki, H.; Yoshimura, Y.; Shuto, S.; Ashida, N.; Konno, K.; Shigeta, S. An alternative synthesis of 9-(5,6-dideoxy-β-D-ribo-hex-5-ynofuranosyl)adenine and its antiviral activity. BioMed. Chem. Lett. 1995, 5, 1685-1688.
9. Cools, M.; De Clercq, E. Correlation between the antiviral activity of acyclic and carbocyclic adenosene analogues in murine L929 cells and thier inhibitory effect on L929 cell S-adenosyl-homocysteine hydrolase. Biochem. Pharmacol. 1989, 38, 1061-1067.
10. (a) Yaginuma, S.; Muto, N.; Tsujino, M.; Sudate, Y.; Hayashi, M.; Otani, M. Studies on neplanocin A, new antitumor antibiotic. I. Producing organism, isolation, and characterization. J. Antibiot. 1981, 34, 359-366.
11. (b) Hayashi, M.; Yaginuma, S.; Yoshioka, H.; Nakatsu, K. Studies on neplanocin A, new antitumor antibiotic. II. Structure determination. J. Antibiot. 1981, 34, 675-680.
12. De Clercq, E. Antiviral and antimetabolic activities of neplanocins. Antimicrob. Agents Chemother. 1985, 28, 84-89.
13. (a) Glazer, R. I.; Knode, M. C. Neplanocin A. A cyclopentenyl analog of adenosine with specificity for inhibiting RNA methylation. J. Biol. Chem. 1984, 259, 12964-12969.
14. (b) Inaba, M.; Nagashima, S.; Tsukagoshi, S.; Sakurai, Y. Biochemical mode of cytotoxic action of neplanocin A in L 1210 leukemic cells. Cancer Res. 1986, 46, 1063-1067.
15. (c) Hoshi, A.; Yoshida, M.; Iigo, M.; Tokugen, R.; Fukukawa, K.; Ueda, T. Antitumor activity of derivatives of neplanocin A in vivo and in vitro. J. Pharmacobio-Dyn. 1986, 9, 202-206.
16. (a) Shuto, S.; Obara, T.; Toriya, M.; Hosoya, M.; Snoeck, R.; Andrei, G.; Balzarini, J.; De Clercq, E. New neplanocin analogues. I. Synthesis of 6′-modified neplanocin A derivatives as broad-spectrum antiviral agents. J. Med. Chem. 1992, 35, 324-331.
17. (b) Shigeta, S.; Mori, S.; Baba, M.; Ito, M.; Honzumi, K.; Nakamura, K.; Oshitani, H.; Numazaki, Y.; Matsuda, A.; Obara, T.; Shuto, S.; De Clercq, E. Antiviral activities of ribavirin, EICAR, and (6′R)-6′-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrob. Agents Chemother. 1992, 36, 435-439.
18. (c) Shuto, S.; Obara, T.; Kosugi, Y.; Toriya, M.; Yaginuma, S.; Shigeta, S.; Matsuda, A. New neplanocin analogues. III. 6′R-Configuration is essential for the antiviral activity of 6′-C-methyl-3-deazaneplanocin A′s. BioMed. Chem. Lett. 1993, 4, 605-608.
19. (d) Shuto, S.; Obara, T.; Itoh, H.; Kosugi, Y.; Saito, Y.; Toriya, M.; Yaginuma, S.; Shigeta, S.; Matsuda, A. New neplanocin analogues. IV. An adenosine deaminase-resistant equivalent of neplanocin A. Chem. Pharm. Bull. 1994, 42, 1688-1690.
20. (e) Obara, T.; Shuto, S.; Saito, Y.; Toriya, M.; Ogawa, K.; Yaginuma, S.; Shigeta, S.; Matsuda, A. New neplanocin analogues. V. A potent adenosylhomocysteine hydrolase inhibitor lacking antiviral activity. Synthesis and antiviral activity of 6′-carboxylic acid derivatives of neplanocin A. Nucleosides Nucleotides, in press.
21. For examples: (a) Borcherding, D. R.; Narayanan, S.; Hasobe, M.; McKee, J. G.; Keller, B. T.; Borchadt, R. T. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase. J. Med. Chem. 1988, 31, 1729-1738. (b) Tsend, C. K. H.; Marquez, V. E.; Fuller, R. W.; Goldstein, B. M.; Arnett, G.; Hollingshead, M.; Driscoll, J. S. Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. J. Med. Chem. 1989, 32, 1442-1446. (c) Hasobe, M.; McKee, J. G.; Borcherding, D. R.; Borchardt, R. T. 9-(trans-2′,trans-3′-Dihydroxycyclopent-4′-enyl)-adenine and 3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity. Antimicrob. Agents Chemother. 1987, 31, 1849-1851.
22. For examples: (a) Borcherding, D. R.; Narayanan, S.; Hasobe, M.; McKee, J. G.; Keller, B. T.; Borchadt, R. T. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase. J. Med. Chem. 1988, 31, 1729-1738. (b) Tsend, C. K. H.; Marquez, V. E.; Fuller, R. W.; Goldstein, B. M.; Arnett, G.; Hollingshead, M.; Driscoll, J. S. Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. J. Med. Chem. 1989, 32, 1442-1446. (c) Hasobe, M.; McKee, J. G.; Borcherding, D. R.; Borchardt, R. T. 9-(trans-2′,trans-3′-Dihydroxycyclopent-4′-enyl)-adenine and 3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity. Antimicrob. Agents Chemother. 1987, 31, 1849-1851.
23. For examples: (a) Borcherding, D. R.; Narayanan, S.; Hasobe, M.; McKee, J. G.; Keller, B. T.; Borchadt, R. T. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase. J. Med. Chem. 1988, 31, 1729-1738. (b) Tsend, C. K. H.; Marquez, V. E.; Fuller, R. W.; Goldstein, B. M.; Arnett, G.; Hollingshead, M.; Driscoll, J. S. Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. J. Med. Chem. 1989, 32, 1442-1446. (c) Hasobe, M.; McKee, J. G.; Borcherding, D. R.; Borchardt, R. T. 9-(trans-2′,trans-3′-Dihydroxycyclopent-4′-enyl)-adenine and 3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity. Antimicrob. Agents Chemother. 1987, 31, 1849-1851.
24. RMNPA showed similar weak inhibitory effects on the growth of parent and Ado kinase deficient FM3A cell lines. The growth inhibitory effect of NPA on the Ado kinase deficient cell lines was significantly reduced compared with that on the parent FM3A cell line. Sasaki, T. Unpublished results.
25. (a) Arita, M.; Okumoto, T.; Saito, T.; Hoshino, Y.; Fukukawa, K.; Shuto, S.; Tsujino, M.; Sakakibara, H.; Ohno, M. Enantioselective synthesis of new analogs of neplanocin A and their biological activity. Carbohydr. Res. 1987, 171, 233-258.
26. (b) Marquez, V. E.; Lim, M., III; Treanor, S. P.; Plowman, J.; Priest, M. A.; Markovac, A.; Khan, M. S.; Kaskar, B.; Driscoll, J. S.; Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties. J. Med. Chem. 1988, 31, 1687-1694.
27. (c) Copp, R. R.; Marquez, V. E. Synthesis of two cyclopentenyl-3-deazapyrimidine carbocyclic nucleosides related to cytidine and uridine. J. Med. Chem. 1991, 34, 208-212.
28. Ali, S. M.; Ramesh, K.; Borchardt, R. T. Efficient enantioselective synthesis of carbocyclic nucleosides and prostaglandin synthons. Tetrahedron Lett. 1990, 31, 1509-1512.
29. Medich, J. R.; Kunnen, K. B.; Johnson, C. R. Synthesis of carbocyclic nucleoside (-)-neplanoccin A. Tetrahedron Lett. 1987, 28, 4131-4134.
30. Rathke, M. W. The preparation of lithio ethyl acetate. A simple procedure for the conversion of aldehydes and ketones to β-hydroxy ester. J. Am. Chem. Soc. 1970, 92, 3222-3223.
31. Oehlschlager, A. C.; Mishra, P.; Dhami, S. Metal-catalyzed rearrangements of allylic esters. Can. J. Chem. 1984, 62, 791-797.
32. Bloch, A.; Robins, M. J.; McCarthy, J. R., Jr. The role of the 5′-hydroxyl group of adenosine in determining substrate specificity for adenosine deaminase. J. Med. Chem. 1968, 10, 908-912.
33. (a) Jones, M. F.; Roberts, S. M. Synthesis of carbocyclic nucleosides; preparation of (-)-5′-homoaristeromycin and analogues. J. Chem. Soc., Perkin Trans. 1 1988, 2927-2932.
34. (b) Vince, R.; Hua, M.; Brownell, J.; Daluge, S.; Lee, F.; Shannon, W. M.; Lavelle, G. C.; Quails, J.; Weisloww, O. S.; Kiser, R.; Canonico, P. G.; Schultz, R. H.; Narayanan, V. L.; Maya, J. G.; Shoemaker, R. H.; Boyd, M. R. Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro. Biochem. Biophys. Res. Commun. 1988, 156, 1046-1053.
35. Kirsi, J. J.; North, J. A.; McKernan, P. A.; Murray, M. K.; Canonico, P. G.; Huggins, J. W.; Srivastava, P. C.; Robins, R. K. Broad-spectrum antiviral activity of 2-β-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent. Antimicrob. Agents Chemother. 1983, 24, 353-361.